Search
besifloxacin (Besivance)
Indications:
- eye infection
- bacterial conjunctivitis
- corneal ulcers [3]
Contraindications:
- pregnancy category: C
Dosage:
- one drop affected eye(s) TID for & days
Suspension: 0.6%
Storage: 15-25 C; protect from light
Antimicrobial activity:
- gram-positive bacteria
- CDC coryneform group G
- Corynebacterium pseudodiphtheriticum
- Corynebacterium striatum
- Staphylococcus aureus
- Staphylococcus epidermidis,
- Staphylococcus hominis
- Staphylococcus lugdunensis
- Streptococcus mitis group,
- Streptococcus oralis
- Streptococcus pneumonia,
- Stretococcus salivarius
- gram-negative bacteria
- Haemophilus influenzae
- Moraxella Lacunata,
Adverse effects:
- uuncommon, reported in < 3% of patients
- blurred vision
- eye pain & redness
- irritation & itching
- headache
Complications:
- overgrowth of nonsusceptible organisms, including fungi especially with prolonged use
Mechanism of action:
- inhibits both bacterial DNA gyrase & topoisomerase IV
Interactions
drug adverse effects of fluoroquinolones
Specific
Besifloxacin Ophthalmic
General
fluoroquinolone
References
- FDA Approves Besivance to Treat Bacterial Conjunctivitis
May 2009
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm162486.htm
- Prescriber's Letter 16(7): 2009
New Drug: Besivance (Besifloxacin Ophthalmic Suspension 0.6%)
Detail-Document#: 250722
(subscription needed) http://www.prescribersletter.com
- Deprecated Reference